For more than 30 years, scientists have studied how the myogenic determination gene number 1 (MYOD) protein binds DNA to modify the gene expression of muscle stem cells. MYOD is a transcription factor ...

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

From innovation in manufacturing to more-flexible regulation and better communication with payers, much needs to happen to ...

Midnight Rider' director Randall Miller argues that the DGA violated its constitution when it expelled him for life in 2022.

Paramount Global is putting its new leadership team in place, including Andy Gordon from Redbird and Kevin MacLellan, a ...

These 10 stocks could mint the next wave of millionaires › Ocugen (NASDAQ:OCGN), a biotechnology company developing gene therapies and regenerative medicine solutions for eye diseases, released its ...

Fortifying their bullpen for the stretch run, the New York Yankees acquired All-Star relievers David Bednar and Camilo Doval in separate deals as they made a flurry of moves Thursday just ahead of ...

The Texas Rangers are adding another reliever in the 11th hour of MLB’s trade deadline. Texas has finalized a deal with the ...

Vinay Prasad, a top official at the Food and Drug Administration, resigned yesterday following a series of controversial ...

The therapies, which are just starting to enter clinical trials, will need to prove clear clinical and quality-of-life ...

PHOENIX -- Former Phoenix Suns guard TyTy Washington Jr. has reportedly agreed to a deal to join the Los Angeles Clippers, according to ESPN's Shams Charania.

President Donald Trump hailed his Japan trade deal as a big win for the U.S. Will Japan see it through?